Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Testosterone replacement therapy for older men.

Borst SE, Mulligan T.

Clin Interv Aging. 2007;2(4):561-6. Review.

2.
3.

Testosterone administration in older men.

Matsumoto AM.

Endocrinol Metab Clin North Am. 2013 Jun;42(2):271-86. doi: 10.1016/j.ecl.2013.02.011. Epub 2013 Mar 22. Review.

PMID:
23702401
4.

Testosterone metabolism and replacement therapy in patients with end-stage renal disease.

Johansen KL.

Semin Dial. 2004 May-Jun;17(3):202-8. Review.

PMID:
15144546
5.

Testosterone replacement therapy for late-onset hypogonadism.

Cunningham GR.

Nat Clin Pract Urol. 2006 May;3(5):260-7. Review.

PMID:
16691239
6.

Androgen replacement in men with hypogonadism and erectile dysfunction.

Albrecht-Betancourt M, Hijazi RA, Cunningham GR.

Endocrine. 2004 Mar-Apr;23(2-3):143-8. Review.

PMID:
15146093
7.

Testosterone treatment in the aging male: myth or reality?

Nigro N, Christ-Crain M.

Swiss Med Wkly. 2012 Mar 19;142:w13539. doi: 10.4414/smw.2012.13539. Review.

8.

Advances in male hormone substitution therapy.

Qoubaitary A, Swerdloff RS, Wang C.

Expert Opin Pharmacother. 2005 Aug;6(9):1493-506. Review.

PMID:
16086637
9.
10.

Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.

Miner M, Canty DJ, Shabsigh R.

Postgrad Med. 2008 Sep;120(3):130-53. doi: 10.3810/pgm.2008.09.1914. Review. Erratum in: Postgrad Med. 2008 Nov;120(4):114.

PMID:
18824832
11.

Testosterone replacement in elderly men.

Baum NH, Crespi CA.

Geriatrics. 2007 Sep;62(9):15-8. Review.

PMID:
17824721
12.

Effects of androgen deficiency and replacement on prostate zonal volumes.

Jin B, Conway AJ, Handelsman DJ.

Clin Endocrinol (Oxf). 2001 Apr;54(4):437-45.

PMID:
11318778
13.

Testosterone supplementation therapy for older men: potential benefits and risks.

Gruenewald DA, Matsumoto AM.

J Am Geriatr Soc. 2003 Jan;51(1):101-15; discussion 115. Review.

PMID:
12534854
14.

Treatment of hypogonadism in men with chronic kidney disease.

Johansen KL.

Adv Chronic Kidney Dis. 2004 Oct;11(4):348-56. Review.

PMID:
15492971
15.

Testosterone deficiency and replacement.

Howell S, Shalet S.

Horm Res. 2001;56 Suppl 1:86-92. Review.

PMID:
11786693
16.

Current and future testosterone delivery systems for treatment of the hypogonadal male.

Pfeil E, Dobs AS.

Expert Opin Drug Deliv. 2008 Apr;5(4):471-81. doi: 10.1517/17425247.5.4.471 . Review.

PMID:
18426387
17.

Testosterone deficiency in older men: a problem worth treating.

McHenry Martin C.

Consult Pharm. 2012 Mar;27(3):152-63. doi: 10.4140/TCP.n.2012.152.

PMID:
22421515
18.

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

Arver S, Dobs AS, Meikle AW, Caramelli KE, Rajaram L, Sanders SW, Mazer NA.

Clin Endocrinol (Oxf). 1997 Dec;47(6):727-37.

PMID:
9497881
19.

Late-onset male hypogonadism and testosterone replacement therapy in primary care.

Brunton SA, Sadovsky R.

J Fam Pract. 2010 Jul;59(7 Suppl):S1-8. Review.

PMID:
20625573
20.
Items per page

Supplemental Content

Write to the Help Desk